Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Somatization of anxiety disorders in the practice of a neurologist: Algorithms and approaches to differentiated treatment

https://doi.org/10.14412/2074-2711-2014-4-81-86

Full Text:

Abstract

As of now, somatization of disorders when its physical symptoms may be caused by mental, psychological, or emotional factors is an extremely common event in clinical practice. The somatization is considered to mean the conversion of mental stress to somatic symptoms. The mechanisms and specific features of somatization disorders within generalized anxiety disorder and panic disorder are of interest. One of the theories about the causes of somatization disorders proposes that somatization is as a way of avoiding psychological stress: it serves to protect from psychological pain, which allows the label of a psychiatric diagnosis to be circumvented in the majority of cases. Some patients unconsciously substitute the
experienced symptoms of anxiety or depression for the development of physical symptoms; anxiety disorders are one of the most common mental disorders. Among various forms of anxiety disorders, panic attacks and generalized anxiety disorders are most often met with neurologists. In some patients, the clinical picture is characterized by a concurrence of both the permanent and paroxysmal symptoms of anxiety, which is not only important to analyze the individual course of the disease, but also responsible for the addressness of a therapeutic approach to a greater extent.
There are data of clinical trials and current algorithms for the therapy of generalized anxiety and related disorders reflecting the complexity of a therapeutic approach. The trials of the therapeutic effectiveness of these or those psychopharmacological agents demonstrate the importance of different groups of drugs in relation to the clinical features of detectable disorders. A number of trials indicate that the use of benzodiazepines (such as phenazepam) may be considered irreplaceable as an emergency care on an exacerbation of anxiety and exceptional therapeutic orientation by using selective antidepressants not always can solve diverse clinical problems.

About the Author

E. G. Mendelevich
Department of Neurology and Rehabilitation, Kazan State Medical University, Ministry of Health of Russia, Kazan, Russia 49, Butlerov St., Kazan 420012
Russian Federation


References

1. Менделевич ВД, Соловьева СЛ. Неврозология и психосоматическая медицина. Москва: МЕДпресс-информ; 2002. 608 с. [Mendelevich VD, Solov'eva SL. Nevrozologiya i psikhosomaticheskaya meditsina [Nevrozology and psychosomatic medicine]. Moscow: MEDpress-inform; 2002. 608 p.]

2. Смулевич АБ, редактор. Психические расстройства в клинической практике. Москва: МЕДпресс-информ; 2011. 720 с. [Smulevich AB, editor. Psikhicheskie rasstroistva v klinicheskoi praktike [Mental disorders in clinical practice]. Moscow: MEDpress-inform; 2011. 720 p.]

3. Собенников ВС, Белялов ФИ. Соматизация и психосоматические расстройства: монография. Иркутск: РИОИГИУВа; 2010. 230 с. [Sobennikov VS, Belyalov FI. Somatizatsiya i psikhosomaticheskie rasstroistva: monografiya [Somatization and psychosomatic frustration: monograph.]. Irkutsk: RIOIGIUVa;

4. 230 p.]

5. Бобров АЕ. Тревожные расстройства:их систематика, диагностика и фармакотерапия. Русский медицинский журнал. 2006;4:328–32. [Bobrov AE. Disturbing frustration: their systematization, diagnostics and pharmacotherapy. Russkii meditsinskii zhurnal. 2006;4:328–32. (In Russ.)]

6. Воробьева ОВ. Парадоксы клинических проявлений и диагностических критериев тревожных расстройств. Эффективная фармакотерапия. 2014;31(3):14–20. [Vorob'eva OV. Paradoxes of clinical manifestations and diagnostic criteria of disturbing frustration. Effektivnaya farmakoterapiya. 2014;31(3):14–20. (In Russ.)]

7. Hansell J, Damour L. Abnormal psychology. Hoboken, NJ: Wiley; 2008. 712 p.

8. National Institutes of Health. Phobias: MedlinePlus. National Library of Medicine – National Institutes of Health. 2011. Retrieved May 12. Available from: http://www.nlm.nih. gov/medlineplus/phobias.html

9. Менделевич ВД. Тест антиципационной состоятельности (прогностической компетентности) – экспериментально-психологическая методика для оценки готовности к невротическим расстройствам. Социальная и клиническая психиатрия. 2003;13(1):35–40. [Mendelevich VD. The test of an antitsipatsionny solvency (predictive competence) – an experimental and psychological technique for an assessment of readiness for neurotic frustration. Sotsial'naya i klinicheskaya psikhiatriya. 2003;13(1):35–40. (In Russ.)]

10. Менделевич ВД. Психиатрическая пропедевтика. 3-е изд., доп. и пер. Москва: МЕД- пресс-информ; 2004. 528 с. [Mendelevich VD. Psikhiatricheskaya propedevtika [Psychiatric propaedeutics]. 3rd ed. Moscow: MEDpress-inform; 2004. 528 p.]

11. Менделевич ВД. Антиципационные механизмы неврозогенеза. Казань: Медицина; 2011. 288 с. [Mendelevich VD. Antitsipatsionnye mekhanizmy nevrozogeneza [Antitsipatic mechanisms of a nevrozogenez]. Kazan': Meditsina; 2011. 288 p.]

12. Baldwin D, Ajel K, Garner M. Pharmacological treatment of generalized anxiety disorder. Curr Top Behav Neurosci. 2010;2:453–67.

13. Baldwin D, Woods R, Lawson R, et al. Efficacy of drug treatments for generalized anxiety disorder: systematic review and metaanalysis. DBMJ. 2011;11:342.

14. Baldwin D, Polkinghorn C. Evidence-based pharmacotherapy of Generalized Anxiety Disorder. Int J Neuropsychopharmacol. 2005;8(2):293–302.

15. Linden M, Bandelow B, Boerner R, et al. The best next drug in the course of generalized anxiety disorders: the «PN-GAD-algorithm». Int J Psychiatry Clin Pract. 2013;17(2):78–89.

16. Abejuela HR, Osser DN. Psychopharmacology algorithm for management of generalized anxiety disorders. 2014. Available from: http://www.harvardsouthshorepsychiatry. org/wpcontent/uploads/2014/05/Revised-Poster-GAD-Algorithm-04-28-14.pdf.

17. Martin J, Sainz-Pardo M, Furukawa T, et al. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol. 2007;21(7):774–82.

18. Inada T, Nazaki S, Inagaki A, et al. Efficacy of diazepam as an anti-anxiety agent: metaanalysis of double-blind, randomized controlled trials carried out in Japan. Hum Psychopharmacol. 2003;18(6):483–7.

19. Чарни Д, Михич Дж, Харрис Э. Клиническая фармакология по Гудману и Гилману. Москва: Практика; 2006. C. 316–37. [Charni D, Mikhich Dzh, Kharris E. Klinicheskaya farmakologiya po Gudmanu i Gilmanu [Clinical pharmacology across Gudman and Gilman]. Moscow: Praktika; 2006. P. 316–37.]

20. Starcevic V. The reappraisal of benzodiazepines in the treatment of anxiety and related disorders. Expert Rev Neurother. 2014;14(11):1275–86. OI: 10.1586/14737175.2014.963057. Epub 2014 Sep 22.

21. Данилов ДС. Алпразолам. Возможности использования на современном этапе развития фармакотерапии психических расстройств. Томск, Новосибирск, Москва: «Иван Федоров»; 2013. 56 с. [Danilov DS. Alprazolam. Vozmozhnosti ispol'zovaniya na sovremennom etape razvitiya farmakoterapii

22. psikhicheskikh rasstroistv [Alprazolam. Possibilities of use at the present stage of development of pharmacotherapy of mental disorders]. Tomsk, Novosibirsk, Moscow: «Ivan Fedorov»; 2013. 56 p.]

23. Сюняков СА, Телешова ЕС. Феназепам – эффективный бензодиазепиновый анксиолитик при терапии психических нарушений пограничного уровня. Психиатрия и психофармакотерапия. 2013;15(6):42–7. [Syunyakov SA, Teleshova ES. Phenazepam is the effective benzodiazepine anxiolytic, used in therapy of borderline psychiatric disorders. Psikhiatriya i psikhofarmakoterapiya. 2013;15(6):42–7. (In Russ.)]

24. Мосолов СН. Основы психофармакотерапии. Москва: Восток; 1996. 288 с. [Mosolov SN. Osnovy psikhofarmakoterapii [Fundamentals of psychopharmacotherapy]. Moscow: Vostok; 1996. 288 p.]

25. Атаманов АА. Генерализованное тревожное и паническое расстройства: динамика, типология, коррекция, профилактика. Автореф. дисс. … докт. мед. наук. Москва; 2014. 52 с. [Atamanov AA. Generalizovannoe trevozhnoe i panicheskoe rasstroistva: dinamika, tipologiya, korrektsiya, profilaktika. Avtoref. diss. … dokt. med. nauk. [Generalized disturbing and panic frustration: dynamics, typology, correction, prevention: Dr. Diss. (Med. Sci.)] Moscow; 2014. 52 p.]


For citation:


Mendelevich E.G. Somatization of anxiety disorders in the practice of a neurologist: Algorithms and approaches to differentiated treatment. Neurology, Neuropsychiatry, Psychosomatics. 2014;6(4):81-86. (In Russ.) https://doi.org/10.14412/2074-2711-2014-4-81-86

Views: 944


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)